Hoya (OTCMKTS:HOCPY - Get Free Report) is expected to be posting its Q1 2026 quarterly earnings results before the market opens on Thursday, August 7th. Analysts expect Hoya to post earnings of $1.05 per share and revenue of $1.47 billion for the quarter.
Hoya (OTCMKTS:HOCPY - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The technology company reported $1.05 EPS for the quarter, hitting analysts' consensus estimates of $1.05. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.47 billion. Hoya had a net margin of 23.22% and a return on equity of 20.43%. On average, analysts expect Hoya to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Hoya Stock Down 8.9%
Shares of Hoya stock traded down $11.30 during trading on Friday, reaching $116.20. The company had a trading volume of 59,434 shares, compared to its average volume of 37,182. The company has a market cap of $39.87 billion, a price-to-earnings ratio of 29.05, a price-to-earnings-growth ratio of 2.29 and a beta of 0.91. The firm's fifty day moving average is $120.19 and its 200-day moving average is $120.07. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.21 and a current ratio of 4.90. Hoya has a fifty-two week low of $97.49 and a fifty-two week high of $148.27.
Analyst Upgrades and Downgrades
Several research firms have commented on HOCPY. Erste Group Bank upgraded shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Friday, May 23rd. The Goldman Sachs Group upgraded shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, July 23rd.
Read Our Latest Report on Hoya
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also

Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.